News

A University of Birmingham-led study of top-flight UK rugby players has identified a method of accurately diagnosing concussion using saliva, paving the way for the first non-invasive clinical test for concussion for use in sport and other settings.

Researchers used neutron scattering to investigate interactions between telaprevir, a drug used to treat hepatitis C infection, and the SARS-CoV-2 main protease.

Why does COVID-19 seem to strike in such a haphazard way, sometimes sparing the 100 year old grandmother, while killing healthy young men and women in the prime of life? A new study by Karen Anderson, Abhishek Singharoy and their colleagues at the Biodesign Institute at Arizona State University, may offer some tentative clues.

New research has found that when it comes to COVID-19, having vitamin D levels above those traditionally considered sufficient may lower the risk of infection, especially for Black people.

Researchers have shown how changes in an environment-sensing protein enable bacteria to survive in different habitats, from the human gut to deep-sea hydrothermal vents.

Researchers have demonstrated that alcohol metabolism can occur in the mouse brain, due to the presence of the enzyme aldehyde dehydrogenase 2 (ALDH2). They also demonstrated that expression of ALDH2 in the mouse cerebellum mediates behavioral effects related to alcohol intoxication. The paper was published in Nature Metabolism.

Scientists have discovered in more detail than ever before how the human body’s immune system reacts to malaria and sickle cell disease. This sheds light on how abnormal red blood cells are recognized and cleared by the immune system and opens therapeutic avenues.

A more energy-efficient method has been developed by scientists which improves the purification of industrial gas by reversing the traditional process.

UT Southwestern researchers have identified the structure of a key member of a family of proteins called nicotinic acetylcholine receptors in three different shapes.

A study recently published in the Science journal has found a solution to applying CAR T cell therapy to solid tumours: programming CAR T cells so that they only kill cancer cells, leaving alone healthy cells that have the same marker protein as cancer cells.